174 related articles for article (PubMed ID: 8840329)
1. The PTH-calcium relationship curve in secondary hyperparathyroidism, an index of sensitivity and suppressibility of parathyroid glands.
Caligara F; Giangrande A; Allaria P; Castiglioni A
Nephrol Dial Transplant; 1996; 11 Suppl 3():136-41. PubMed ID: 8840329
[TBL] [Abstract][Full Text] [Related]
2. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
3. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Calliada F; Marcelli D; Imbasciati E
Am J Kidney Dis; 1996 Nov; 28(5):704-12. PubMed ID: 9158208
[TBL] [Abstract][Full Text] [Related]
5. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P
Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism.
Kinugasa E; Akizawa T; Takahashi J; Nabeshima K; Ogata H; Nakayama F; Ideura T
Nephrol Dial Transplant; 2002; 17 Suppl 10():20-7. PubMed ID: 12386265
[TBL] [Abstract][Full Text] [Related]
8. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
[TBL] [Abstract][Full Text] [Related]
9. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
10. Calcium-sensing by parathyroid glands in secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Van Herle AJ; Juppner H; Salusky IB
J Clin Endocrinol Metab; 1998 Aug; 83(8):2765-72. PubMed ID: 9709944
[TBL] [Abstract][Full Text] [Related]
11. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
Messa P; Mioni G; Turrin D; Guerra UP
Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
[TBL] [Abstract][Full Text] [Related]
12. A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy.
Felsenfeld AJ; Rodriguez M; Dunlay R; Llach F
Nephrol Dial Transplant; 1991; 6(4):244-51. PubMed ID: 1881578
[TBL] [Abstract][Full Text] [Related]
13. Lack of influence of recombinant human erythropoietin on parathyroid function in hemodialysis patients with secondary hyperparathyroidism.
Lai YH; Tsai JC; Chen HC; Guh JY; Hwang SJ; Tsai JH
Nephron; 1995; 70(2):223-8. PubMed ID: 7566308
[TBL] [Abstract][Full Text] [Related]
14. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
Salusky IB; Goodman WG
Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.
Malberti F; Surian M; Cosci P
Nephrol Dial Transplant; 1992; 7(8):822-8. PubMed ID: 1325615
[TBL] [Abstract][Full Text] [Related]
16. Calcium-mediated parathyroid hormone suppression to assess progression of secondary hyperparathyroidism during treatment among incident dialysis patients.
Rodriguez M; Ureña-Torres P; Pétavy F; Cooper K; Farouk M; Goodman WG
J Clin Endocrinol Metab; 2013 Feb; 98(2):618-25. PubMed ID: 23365129
[TBL] [Abstract][Full Text] [Related]
17. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
el-Hajj Fuleihan G; Chen CJ; Rivkees SA; Marynick SP; Stock J; Pallotta JA; Brown EM
J Clin Endocrinol Metab; 1989 Oct; 69(4):860-7. PubMed ID: 2778039
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid gland function in the uremic rabbit.
Bas S; Bas A; Estepa JC; Mayer-Valor R; Rodriguez M; Aguilera-Tejero E
Domest Anim Endocrinol; 2004 Mar; 26(2):99-110. PubMed ID: 14757183
[TBL] [Abstract][Full Text] [Related]
19. The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.
Rodriguez M; Felsenfeld AJ; Williams C; Pederson JA; Llach F
J Am Soc Nephrol; 1991 Nov; 2(5):1014-20. PubMed ID: 1760537
[TBL] [Abstract][Full Text] [Related]
20. Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism.
Goodman WG; Belin T; Gales B; Juppner H; Segre GV; Salusky IB
Kidney Int; 1995 Nov; 48(5):1553-8. PubMed ID: 8544413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
